Tumor a tumor: metástasis de carcinoma ductal infiltrante de mama sobre carcinoma de células cromófobas de riñón

Toro-Zambrano, Weimar; Gómez-Durán, Aúrea; Félix Conde-Martin, Antonio Félix; Mayoral-Guisado, Carlos; Ruiz-Guerrero, Antonio; Rubio-Fernández, Alejandro.
Rev. esp. patol ; 50(1): 58-63, ene.-mar. 2017.
Artículo en Español | IBECS (España) | ID: ibc-159066

Documentos relacionados

  1. Papillary Renal Cell Carcinoma: Evolving Classification by Combined Morphologic and Molecular Means.
  2. Phase I Trial of Combination Therapy With Avelumab and Cabozantinib in Patients With Newly Diagnosed Metastatic Clear Cell Renal Cell Carcinoma.
  3. Molecular differences in renal cell carcinoma between males and females.
  4. Predictive factors and oncological outcomes of pathological T3a upstaging in patients with clinical T1 renal cell carcinoma undergoing partial nephrectomy.
  5. Localised non-metastatic sarcomatoid renal cell carcinoma: a 31-year externally verified study.
  6. Machine-learning approach for prediction of pT3a upstaging and outcomes of localized renal cell carcinoma (UroCCR-15).
  7. Multi-regional Sequencing Elucidates the Evolution of Clear Cell Renal Cell Carcinoma.
  8. Prognostic Significance of Tumor-Associated Inflammation in Renal Cell Carcinoma.
  9. Papillary renal cell carcinoma: a single institutional study of 199 cases addressing classification, clinicopathologic and molecular features, and treatment outcome.
  10. What's new in the WHO 2022 classification of kidney tumours?